Pre-clinical modeling of cutaneous melanoma
Despite the new targeted and immunotherapies for metastatic melanoma, several patients show therapeutic plateau. Here, the authors review the current pre-clinical models of cutaneous melanoma and discuss their strengths and limitations that may help with overcoming therapeutic plateau.
Guardado en:
Autores principales: | Vito W. Rebecca, Rajasekharan Somasundaram, Meenhard Herlyn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0003348e52b44f61bda3eaf9e47fe9f7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma.
por: Jinah Kim, et al.
Publicado: (2011) -
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
por: Johannes Griss, et al.
Publicado: (2019) -
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
por: Rebecca Adams, et al.
Publicado: (2021) -
Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
por: Alessandra Buja, et al.
Publicado: (2021) -
HSP105 expression in cutaneous malignant melanoma: Correlation with clinicopathological characteristics.
por: Ke-Jun Chen, et al.
Publicado: (2021)